The global biosimulation market is growing at a CAGR of nearly 16.0% during the forecast period. The major factors that are augmenting the growth of the market is urgency to develop and promote modern drugs. Furthermore, rising trend of surrogacy, growing infrastructure and increasing healthcare spending by government are also estimated to be the major factors that are contributing...

The global biosimulation market is on track for significant expansion, with a projected value of USD 11.24 billion by 2030, according to a recent market analysis. This represents a remarkable growth of 16.7% CAGR from 2023, indicating the increasing adoption and value placed on biosimulation across various industries. Biosimulation leverages computational modeling and simulation techniques to...

The global pharmacovigilance and drug safety software market is poised for substantial growth, with an expected value of USD 14.86 billion by the year 2030. Recent market analysis indicates that the market size for pharmacovigilance and drug safety software was valued at USD 6.83 billion in 2022, reflecting a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 10.2% over the...